Matilda Esselius
YOU?
Author Swipe
View article: ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN Open
Summary paragraph One of the key features of high-risk neuroblastoma (NB) is MYCN -amplification. While MYCN is still regarded as therapeutically challenging despite intensive efforts to find targeting compounds, inhibitors against Anaplas…